|
1
|
Espat NJ, Lewis JJ, Leung D, et al:
Conventional hemangiopericytoma: modern analysis of outcome.
Cancer. 95:1746–1751. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koch M, Nielsen GP and Yoon SS: Malignant
tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and
hemangiopericytomas. J Surg Oncol. 97:321–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mena H, Ribas JL, Pezeshkpour GH, Cowan DN
and Parisi JE: Hemangiopericytoma of the central nervous system: a
review of 94 cases. Hum Pathol. 22:84–91. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scheithauer BW, Fuller GN and VandenBerg
SR: The 2007 WHO classification of tumors of the nervous system:
controversies in surgical neuropathology. Brain Pathol. 18:307–316.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu W, Shi JX, Cheng HL, et al:
Hemangiopericytomas in the central nervous system. J Clin Neurosci.
16:519–523. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jääskeläinen J, Louis DN, Paulus W and
Haltia MJ: Haemangiopericytoma. Pathology and Genetics of the
Nervous System Tumors. Kleihues P and Cavenee WK: WHO
Classification of Tumors. IARC Press; Lyon: pp. 190–192. 2000
|
|
7
|
Kim JH, Jung HW, Kim YS, et al: Meningeal
hemangiopericytomas: long-term outcome and biological behavior.
Surg Neurol. 59:47–54. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kleihaus P, Louis DN, Burger PC, et al:
The WHO classification of tumors of the nervous system. J
Neuropathol Exp Neurol. 61:215–229. 2002.
|
|
9
|
Galanis E, Buckner JC, Scheithauer BW, et
al: Management of recurrent meningeal hemangiopericytoma. Cancer.
82:1915–1920. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fountas KN, Kapsalaki E, Kassam M, et al:
Management of intracranial meningeal hemangiopericytomas: outcome
and experience. Neurosurg Rev. 29:145–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sundaram C, Uppin SG, Uppin MS, et al: A
clinicopathological and immunohistochemical study of central
nervous system hemangiopericytomas. J Clin Neurosci. 17:469–472.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Akiyama M, Sakai H, Onoue H, Miyazaki Y
and Abe T: Imaging intracranial hemangiopericytomas: study of seven
cases. Neuroradiology. 46:194–197. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sibtain NA, Butt S and Connor SE: Imaging
features of central nervous system hemangiopericytomas. Eur Radiol.
17:1685–1693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tashjian VS, Khanlou N, Vinters HV, et al:
Hemangiopericytoma of the cerebello pontine angle: a case report
and review of the literature. Surg Neurol. 72:290–295. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soyuer S, Chang EL, Selek U, et al:
Intracranial meningeal hemangiopericytoma: the role of
radiotherapy: report of 29 cases and review of the literature.
Cancer. 100:1491–1497. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Olson C, Yen CP, Schlesinger D and Sheehan
J: Radiosurgery for intracranial hemangiopericytoma: outcomes after
initial and repeat Gamma Knife surgery. J Neurosurgery.
112:133–139. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rutkowski MJ, Sughrue ME, Kane AJ, et al:
Predictors of mortality following treatment of intracranial
hemangiopericytoma. Neurosurgery. 113:340–351. 2010.
|
|
18
|
Barba I, Moreno A, Martinez-Pérez I, et
al: Magnetic resonance spectroscopy of brain hemangiopericytomas:
high myoinositol concentrations and discrimination from
meningiomas. J Neurosurg. 94:55–60. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fortuniak J, Jaskólski DJ, Stefańczyk L,
Zawirski M and Gajewicz W: Magnetic resonance imaging of rare
intracranial neoplasms - role of the in vivo 1 h spectroscopy in
the radiological differential diagnostics. Cen Eur Neurosurg.
71:181–188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cho YD, Choi GH, Lee SP and Kim JK:
(1)H-MRS metabolic patterns for distinguishing between meningiomas
and other brain tumors. Magn Reson Imaging. 21:663–672. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hattingen E, Pilatus U, Good C, et al: An
unusual intraventricular haemangiopericytoma: MRI and spectroscopy.
Neuroradiology. 45:386–389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Beckonert O, Coen M, Keun HC, et al:
High-resolution magic-angle-spinning NMR spectroscopy for metabolic
profiling of intact tissue. Nat Protoc. 5:1019–1032. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
DeFeo EM and Cheng LL: Charactrizing human
cancer metabolomics by ex vivo 1HRMAS MRS. Technol Cancer Res
Treat. 9:381–391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moestue S, Sitter B, Bathen TF, Tessem MB
and Gribbestad IS: HR MAS MR spectroscopy in metabolic
characterization of cancer. Curr Top Med Chem. 11:2–26. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ricci R, Bacci A, Tugnoli V, et al:
Metabolic findings on 3T 1H-MR spectroscopy in
peritumoral brain edema. Am J Neuroradiol. 28:1287–1291. 2007.
|
|
26
|
Chernov MF, Kubo O, Hayashi M, et al:
Proton MRS of the peritumoral brain. J Neurol Sci. 228:137–142.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bax A: A spatially selective composite 90°
radiofrequency pulse. J Magn Reson. 65:142–145. 1985.
|
|
29
|
Meiboom S and Gill D: Modified spin-echo
method for measuring nuclear relaxation time. Rev Sci Instrum.
20:688–691. 1958. View Article : Google Scholar
|
|
30
|
Wu D, Chen A and Johnson CS Jr: An
improved diffusion ordered spectroscopy experiment incorporating
bipolar gradient pulses. Magn Reson Series A. 115:260–264. 1995.
View Article : Google Scholar
|
|
31
|
Jeener J: Pulse pair techniques in high
resolution NMR. Ampere International Summer School; Basko Polje:
1971
|
|
32
|
Aue WP, Bartholdi E and Ernst RR:
Two-dimensional spectroscopy. Application to nuclear magnetic
resonance. J Chem Phys. 64:2229–2246. 1976. View Article : Google Scholar
|
|
33
|
Braunschweiler L and Ernst RR: Coherence
transfer by isotropic mixing: application to proton correlation
spectroscopy. J Magn Reson. 53:521–528. 1983.
|
|
34
|
Bax A and Davis DG: MLEV-17-based
two-dimensional homonuclear magnetization transfer spectroscopy. J
Magn Res. 65:355–360. 1985.
|
|
35
|
Bodenhausen G and Ruben DJ: Natural
abundance nitrogen-15 NMR by enhanced eteronuclear spectroscopy.
Chem Phys Lett. 69:185–189. 1980. View Article : Google Scholar
|
|
36
|
Fan TMW: Metabolite profiling by one- and
two-dimensional NMR analysis of complex mixtures. Prog Nuc Mag Res
Spec. 28:161–219. 1996. View Article : Google Scholar
|
|
37
|
Wishart DS, Tzur D, Knox C, et al: HMDB:
the human metabolome database. Nucleic Acids Res. 35:D521–D526.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Opstad KS, Wright AJ, Bell BA, et al:
Correlations between in vivo 1H MRS and ex
vivo 1H HRMAS metabolite measurements in adult human
gliomas. J Magn Reson Imag. 31:289–297. 2010.
|
|
39
|
Harting I, Jost G, Hacke N and Hartmann M:
Magnetic resonance spectroscopy of brain tumours. Nervenarzt.
76:403–417. 2005.PubMed/NCBI
|
|
40
|
Kashiwaya Y, Pawlosky R, Markis W, et al:
A ketone ester diet increases brain malonyl-CoA and uncoupling
proteins 4 and 5 while decreasing food intake in the normal Wistar
Rat. J Biol Chem. 285:25950–25956. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yudkoff M, Daikhin Y, Melø TM, et al: The
ketogenic diet and brain metabolism of amino acids: relationship to
the anticonvulsant effect. Annul Rev Nutr. 27:415–430. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Skinner R, Trujillo A, Ma X and Beierle
EA: Ketone bodies inhibit the viability of human neuroblastoma
cells. J Pediatr Surg. 44:212–216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Suzuki M, Suzuki M, Kitamura Y, et al:
β-hydroxybutyrate, a cerebral function improving agent, protects
rat brain against ischemic damage caused by permanent and transient
focal cerebral ischemia. Jpn J Pharmacol. 89:36–43. 2002.
|
|
44
|
Chernov MF, Kawamata T, Amano K, et al:
Possible role of single-voxel (1)H-MRS in differential diagnosis of
suprasellar tumors. J Neurooncol. 91:191–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Demougeot C, Garnier P, Mossiat C, et al:
N-Acetylaspartate, a marker of both cellular dysfunction and
neuronal loss: its relevance to studies of acute brain injury. J
Neurochem. 77:408–415. 2001. View Article : Google Scholar
|
|
46
|
Moffett JR, Ross B, Arun P, et al:
N-Acetylaspartate in the CNS: from neurodiagnostics to
neurobiology. Prog Neurobiol. 81:89–131. 2007. View Article : Google Scholar
|
|
47
|
Rigotti DJ, Inglese M and Gonen O:
Whole-brain N-acetylaspartate as a surrogate marker of
neuronal damage in diffuse neurologic disorders. Am J Neuroradiol.
28:1843–1849. 2007.
|
|
48
|
Tugnoli V, Schenetti L, Mucci A, et al:
Ex vivo HR-MAS MRS of human meningiomas: a comparison with
in vivo 1H MR spectra. Int J Mol Med. 18:859–869.
2006.
|
|
49
|
Monleon D, Morales JM, Gonzalez-Darder J,
et al: Benign and atypical meningioma metabolic signatures by
high-resolution magic-angle spinning molecular profiling. J
Proteome Res. 7:2882–2888. 2008. View Article : Google Scholar : PubMed/NCBI
|
